Cargando…

Racial disparities in opioid prescription and pain management among breast cancer survivors

BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sunny Jung, Retnam, Reuben P., Sutton, Arnethea L., Edmonds, Megan C., Bandyopadhyay, Dipankar, Sheppard, Vanessa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225217/
https://www.ncbi.nlm.nih.gov/pubmed/36916310
http://dx.doi.org/10.1002/cam4.5755
_version_ 1785050352992649216
author Kim, Sunny Jung
Retnam, Reuben P.
Sutton, Arnethea L.
Edmonds, Megan C.
Bandyopadhyay, Dipankar
Sheppard, Vanessa B.
author_facet Kim, Sunny Jung
Retnam, Reuben P.
Sutton, Arnethea L.
Edmonds, Megan C.
Bandyopadhyay, Dipankar
Sheppard, Vanessa B.
author_sort Kim, Sunny Jung
collection PubMed
description BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiation and Persistence (WHIP) study (n = 595), a longitudinal study of hormonal receptor‐positive breast cancer survivors. Upon study enrollment, patients completed a survey assessing an array of psychological, behavioral, and treatment outcomes, including adjuvant endocrine therapy (AET)‐induced symptoms, and provided a saliva biospecimen. Opioid prescription records were extracted from the health maintenance organizations (HMOs) pharmacy database. The final analytic sample included women with complete HMO pharmacy records for 1 year. RESULTS: There were 251 eligible patients, of which 169 (67.3%) were White. The average age was 61.09 years old (SD = 11.07). One hundred seventy‐two patients (68.5%) had received at least one opioid medication and 37.1% were prescribed opioids longer than 90 days (n = 93). Sixty‐four Black patients (78%) had a record of being prescribed with opioids compared to 64% of White patients (n = 108, p = 0.03). Black patients reported worse vasomotor, neuropsychological, and gastrointestinal symptoms, as well as lower quality of life and greater healthcare discrimination than White patients (p's < 0.05). Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014). CONCLUSION: Findings indicate that there are racial differences in opioid prescriptions supplied for pain management and symptomatic outcomes. Future research is needed to understand the causes of disparities in cancer pain management and symptomatic outcomes.
format Online
Article
Text
id pubmed-10225217
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102252172023-05-29 Racial disparities in opioid prescription and pain management among breast cancer survivors Kim, Sunny Jung Retnam, Reuben P. Sutton, Arnethea L. Edmonds, Megan C. Bandyopadhyay, Dipankar Sheppard, Vanessa B. Cancer Med RESEARCH ARTICLES BACKGROUND: We examined whether there are racial disparities in pain management, opioid medicine prescriptions, symptom severity, and quality of life constructs in breast cancer survivors. METHODS: We conducted a secondary analysis of longitudinal data from the Women's Hormonal Therapy Initiation and Persistence (WHIP) study (n = 595), a longitudinal study of hormonal receptor‐positive breast cancer survivors. Upon study enrollment, patients completed a survey assessing an array of psychological, behavioral, and treatment outcomes, including adjuvant endocrine therapy (AET)‐induced symptoms, and provided a saliva biospecimen. Opioid prescription records were extracted from the health maintenance organizations (HMOs) pharmacy database. The final analytic sample included women with complete HMO pharmacy records for 1 year. RESULTS: There were 251 eligible patients, of which 169 (67.3%) were White. The average age was 61.09 years old (SD = 11.07). One hundred seventy‐two patients (68.5%) had received at least one opioid medication and 37.1% were prescribed opioids longer than 90 days (n = 93). Sixty‐four Black patients (78%) had a record of being prescribed with opioids compared to 64% of White patients (n = 108, p = 0.03). Black patients reported worse vasomotor, neuropsychological, and gastrointestinal symptoms, as well as lower quality of life and greater healthcare discrimination than White patients (p's < 0.05). Black patients were more likely to be prescribed opioids for 90 days or longer compared to White patients, when controlling for age, marital status, income, body mass index (BMI), cancer stage, and chemotherapy status (adjusted Odds Ratio = 2.72, p = 0.014). CONCLUSION: Findings indicate that there are racial differences in opioid prescriptions supplied for pain management and symptomatic outcomes. Future research is needed to understand the causes of disparities in cancer pain management and symptomatic outcomes. John Wiley and Sons Inc. 2023-03-14 /pmc/articles/PMC10225217/ /pubmed/36916310 http://dx.doi.org/10.1002/cam4.5755 Text en © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle RESEARCH ARTICLES
Kim, Sunny Jung
Retnam, Reuben P.
Sutton, Arnethea L.
Edmonds, Megan C.
Bandyopadhyay, Dipankar
Sheppard, Vanessa B.
Racial disparities in opioid prescription and pain management among breast cancer survivors
title Racial disparities in opioid prescription and pain management among breast cancer survivors
title_full Racial disparities in opioid prescription and pain management among breast cancer survivors
title_fullStr Racial disparities in opioid prescription and pain management among breast cancer survivors
title_full_unstemmed Racial disparities in opioid prescription and pain management among breast cancer survivors
title_short Racial disparities in opioid prescription and pain management among breast cancer survivors
title_sort racial disparities in opioid prescription and pain management among breast cancer survivors
topic RESEARCH ARTICLES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225217/
https://www.ncbi.nlm.nih.gov/pubmed/36916310
http://dx.doi.org/10.1002/cam4.5755
work_keys_str_mv AT kimsunnyjung racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors
AT retnamreubenp racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors
AT suttonarnetheal racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors
AT edmondsmeganc racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors
AT bandyopadhyaydipankar racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors
AT sheppardvanessab racialdisparitiesinopioidprescriptionandpainmanagementamongbreastcancersurvivors